embecta completes £100m acquisition of UK-based Owen Mumford to bolster drug delivery portfolio
US diabetes care company embecta has finalised its acquisition of Owen Mumford, gaining access to the Aidaptus next-generation auto-injector platform as it accelerates its transition into a broad-based medical supplies company